Daxia means "Big Hero"
We love what heroes look like.
Being Inclusive of All Patients in Clinical Studies
Daxia is a health market research and patient advocacy organization focused on community outreach in Black and Hispanic populations where health disparities and lack of clinical trial options often exist. Black and Hispanic Americans represent only 10% of patients in clinical trials meaning inadequate data in drug efficacy for minorities and we strive to change that. We engage and train underrepresented physicians and their staff so that they are research ready and have the equal opportunity to participate in health commercial marketing and advertising focus groups, surveys, phone / video interviews and virtual events where their voices are heard. We then work closely with healthcare advertising organizations, integrated with global CROs, to ensure unique perspectives are part of Pharma marketing campaigns. Our participating investigators and patients are based all throughout the United States in areas of neurology, oncology, gastroenterology, metabolic disease, autoimmune, rare disease, obstetrics, and cardiology.
Daxia is Derived From the Chinese Word “ Da Xia” Meaning “Big Hero”
We strive to serve the biggest heroes — our patient and physician communities who are fighting disease every day. Pharma can be a big hero too by bringing new treatments and even cures to all types of people, making sure that your trials and therapeutic products reach culturally diverse individuals. Do something real to make a difference.
5 Countries 155 US Oncologists 455 Global HCPs
18 countries, 138 sites, 654 patients enrolled, 48% African American, 31% Hispanic
15 countries, 110 sites, 781 RRMS patients enrolled, 40% African American, 25% Hispanic
12 Countries, 140 Sites, 2000 patients enrolled, 62% African American, 10% Hispanic
4 Countries, 150 US Nephrologists, 410 worldwide HCPs
18 Countries, 152 sites, 2500 patients enrolled, 38% African American, 45% Hispanic
5 Countries, 210 US patients, 475 worldwide, 50% African American, 18% Hispanic
12 Countries, 112 Sites, 2245 patients enrolled, 55% African American, 28% Hispanic
10 Countries, 140 Sites, 1700 patients enrolled, 46% African American, 30% Hispanic
6 Countries, 210 Sites, 4000 PCR+ patients enrolled, 58% African American, 20% Hispanic